Podophyllotoxin
Topoisomerase Inhibitor · Treatment of anogenital warts
Mechanism
Podophyllotoxin binds to tubulin at the colchicine-binding site, inhibiting microtubule assembly and arresting cells in mitosis. However, its semisynthetic derivatives etoposide and teniposide have a completely different mechanism — they inhibit topoisomerase II rather than tubulin. Applied topically for genital warts, podophyllotoxin causes necrosis of condylomata through its antimitotic effect on the rapidly proliferating HPV-infected epithelium.
Indications
Dosing
- Adult
- Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of five 3-day treatment courses
- Max dose
- maximum 50 single applications (‘loops’) per session
Contraindications
- Should not be used on large areas of skin
- broken skin
- sensitive skin
- mucous membranes
- avoid contact with eyes
- avoid contact with inside of ears
- avoid contact with inside of nostrils
- avoid contact with lips
- avoid occlusive dressings on treated area
- Impaired peripheral circulation
- not suitable for application to face
- patients with diabetes at risk of neuropathic ulcers
- significant peripheral neuropathy
Side effects
- Neoplasms
Pregnancy & lactation
Not absorbed from skin, but manufacturer advises avoid.
Not absorbed from skin; ensure infant does not come in contact with treated area for 6 hours after application.
Related guidelines
Other Topoisomerase Inhibitor drugs
Ask House about Podophyllotoxin
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Katzung·Verified: 2026-05-10 · House clinical team